Regulatory & Safety

Rhodia losses

Rhodia losses

French specialty chemicals company Rhodia today reported net sales
of €6,617 million in 2002, representing a nine per cent drop
compared with 2001.

Agreeing on liver cells

Agreeing on liver cells

Exten Industries reported today that its wholly owned subsidiary,
MultiCell Technologies, a liver cell engineering and research
organisation in Warwick, US has just signed a nonexclusive license
agreement with a major pharmaceutical...

GW refutes media comments

GW refutes media comments

In relation to recent media comments relating to its
commercialisation discussions UK company GW Pharmaceuticals said in
a statement this week that it has consistently stated its
commercial strategy 'to be to enter into partnerships...

Degussa divestments complete

Degussa divestments complete

German chemicals company Degussa has sold its Frankfurt/Main-based
biopharmaceutical company Zentaris to Canadian firm AEterna
Laboratories for approximately €50 million, the company said last
week. The move marks the much-talked...